InsiderDB
Sign inStart free trial

Rep. Dan Newhouse sold Elevance Health (ELV)

Rep. Dan Newhouse (R-WA-4) · $1K–$15K · traded Apr 11, 2025

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Spouse
Traded
Apr 11, 2025
Disclosed
May 16, 2025
Days to disclose
35
Asset type
Stock
As filed
Elevance Health, Inc. Common Stock
Industry
Medical - Healthcare Plans · Healthcare
Official filing ↗All of Newhouse's tradesAll Congress trades in ELV

Other trades in this filing

All of Newhouse's trades →

Recent Congress trades in ELV

Company context for ELV

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ELVLobbying report·Lobbying disclosures

    ELV: third_quarter 2026 lobbying report

    Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment. Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.

    Public: Oct 20, 2026, 3:32 PM EDTOriginal source ↗
  2. ELVLobbying report·Lobbying disclosures

    ELV: third_quarter 2026 lobbying report

    Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Health Care Price Certainty for All Americans Act (H.R. 9645) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Affairs Community Cares program The Take Care of Americas Veterans Act (H.R. 92

    Public: Oct 20, 2026, 2:52 PM EDTOriginal source ↗
  3. ELVLobbying report·Lobbying disclosures

    ELV: third_quarter 2026 lobbying report

    Federal budget issues Lobbying related to health care access, Medicare, and Medicaid policy Lobbying related to health care access Tax policy Lobbying related to health care access, Medicare, and Medicaid policy

    Public: Oct 20, 2026, 2:24 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.